About University of Minnesota, Department of Neurology
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Pharnext SA
2
Cephalon
1
Immunovant Sciences GmbH
1
Italfarmaco
1
Clinical Trials at University of Minnesota, Department of Neurology
During the past decade, University of Minnesota, Department of Neurology conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on
average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Safety and Efficacy Study of CEP-1347 in the Treatment of Parkinson's Disease
2002-03-01
2005-08-01
Terminated
806
Phase III Trial Assessing the Efficacy and Safety of PXT3003 in CMT1A Patients (PLEO-CMT)
2015-12-01
2018-08-01
Completed
323
Clinical Study to Evaluate the Efficacy and Safety of Givinostat in Ambulant Patients With Duchenne Muscular Dystrophy
2017-06-06
2022-02-22
Completed
179
Assessing Long Term Safety and Tolerability of PXT3003 in Patients With Charcot-Marie-Tooth Disease Type 1A
2017-03-07
2024-12-31
Active, not recruiting
187
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "University of Minnesota, Department of Neurology"
#1 collaborator was "Syneos Health" with 2 trials as a collaborator, "H. Lundbeck A/S" with 1 trials as a collaborator, "Premier Research Group plc" with 1 trials as a collaborator, "SynteractHCR" with 1 trials as a collaborator and "The Parkinson Study Group" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were
collaborators in the rest 5 trials.
Clinical Trials Conditions at University of Minnesota, Department of Neurology
According to Clinical.Site data, the most researched conditions in "University of Minnesota, Department of Neurology" are
"Charcot-Marie-Tooth Disease Type 1A" (1 trials), "Charcot-Marie-Tooth Disease, Type IA" (1 trials), "Duchenne Muscular Dystrophy" (1 trials), "Myasthenia Gravis" (1 trials) and "Parkinson Disease" (1 trials). Many other conditions were trialed in "University of Minnesota, Department of Neurology" in a lesser frequency.
Clinical Trials Intervention Types at University of Minnesota, Department of Neurology
Most popular intervention types in "University of Minnesota, Department of Neurology" are "Drug" (5 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "placebo" (2 trials), "CEP-1347 10mg" (1 trials), "CEP-1347 50mg" (1 trials), "CEP1347 25mg" (1 trials) and "PXT3003" (1 trials). Other intervention names were less common.
Clinical Trials Genders at University of Minnesota, Department of Neurology
The vast majority of trials in "University of Minnesota, Department of Neurology" are
4 trials for "All" genders and 1 trials for "Male" genders.
Clinical Trials Status at University of Minnesota, Department of Neurology
Currently, there are NaN active trials in "University of Minnesota, Department of Neurology".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in University of Minnesota, Department of Neurology,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in University of Minnesota, Department of Neurology, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".